Evidence map›Paper›PMID 35792968›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2022

Correction to: A Brain-Penetrant Stearoyl-CoA Desaturase Inhibitor Reverses α-Synuclein Toxicity.

Silke Nuber, Chee Yeun Chung, Daniel F Tardiff, Pascal A Bechade, Thomas D McCaffery, Kazuma Shimanaka, Jeonghoon Choi, Belle Chang, Waseem Raja, Esther Neves and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Silke NuberAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US. snuber@bwh.harvard.edu.
Chee Yeun ChungYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US. cychung@me.com.ORCID http://orcid.org/0000-0002-5515-650X
Daniel F TardiffYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Pascal A BechadeAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US.
Thomas D McCafferyAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US.
Kazuma ShimanakaAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US.
Jeonghoon ChoiYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Belle ChangYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Waseem RajaYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Esther NevesYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Christopher BurkeYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Xin JiangYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Ping XuYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Vikram KhuranaAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US.
Ulf DettmerAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US.
Saranna FanningAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US.
Kenneth J RhodesYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.
Dennis J SelkoeAnn Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women Hospital and Harvard Medical School, 60 Fenwood Rd, Boston, MA, 02115, US.
Robert H ScannevinYumanity Therapeutics, 40 Guest Street, Boston, MA, 02135, US.

Funding

Biologically novel mouse models of PD with progressive synucleinopathy and early-onset tremor and motor deficits responsive to L-DOPAR01NS109510 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI NUBER, SILKE · 2019 to 2023
$1.9M
NINDS NIH HHS R01 NS109510
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35792968
PMCPMC9587197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.